Farydak Interactions
There are 666 drugs known to interact with Farydak (panobinostat), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 357 are major, 307 are moderate, and 2 are minor.
- View all 666 medications that may interact with Farydak
- View Farydak alcohol/food interactions (1)
- View Farydak disease interactions (5)
Most frequently checked interactions
View interaction reports for Farydak (panobinostat) and the medicines listed below.
- Actemra (tocilizumab)
- acyclovir
- Adcetris (brentuximab)
- Adempas (riociguat)
- Avastin (bevacizumab)
- Banzel (rufinamide)
- Blincyto (blinatumomab)
- Enbrel (etanercept)
- Entyvio (vedolizumab)
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Juxtapid (lomitapide)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- Ofev (nintedanib)
- Orencia (abatacept)
- Pomalyst (pomalidomide)
- Prolia (denosumab)
- Promacta (eltrombopag)
- Ravicti (glycerol phenylbutyrate)
- Revlimid (lenalidomide)
- Sabril (vigabatrin)
- Soliris (eculizumab)
- Sprycel (dasatinib)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Thalomid (thalidomide)
- Truvada (emtricitabine / tenofovir disoproxil)
- Votrient (pazopanib)
- Zydelig (idelalisib)
Farydak alcohol/food interactions
There is 1 alcohol/food interaction with Farydak (panobinostat).
Farydak disease interactions
There are 5 disease interactions with Farydak (panobinostat) which include:
Report options
More about Farydak (panobinostat)
- Farydak consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: histone deacetylase inhibitors
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Darzalex
Darzalex (daratumumab) is a target therapy used to treat multiple myeloma. Includes DARZALEX uses ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Pomalyst
Pomalyst (pomalidomide) is used to treat multiple myeloma and AIDS-related Kaposi sarcoma. Includes ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
